Publication Name	World Journal of Gastroenterology
Manuscript ID	14656
Country	China

Received	2014-10-18 13:05
Peer-Review Started	2014-10-19 15:34
To Make the First Decision	2014-12-02 09:23
Return for Revision	2014-12-03 18:30
Revised	2014-12-12 14:46
Second Decision	2015-02-11 22:51
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-02-12 17:36
Articles in Press	2015-02-13 11:19
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-04-18 17:55
Typeset the Manuscript	2015-05-28 18:01
Publish the Manuscript Online	2015-06-18 17:32

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Meta-Analysis
Article Title	Standard chemotherapy with cetuximab for treatment of colorectal cancer
Manuscript Source	Unsolicited Manuscript
All Author List	Xin-Xiang Li, Lei Liang, Li-Yong Huang and San-Jun Cai
Funding Agency and Grant Number
Corresponding Author	San-Jun Cai, MD, Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai 200032, China. cai_sanjunsci@163.com
Key Words	Cetuximab; KRAS; Standard chemotherapy; Metastatic colorectal cancer; Meta-analysis
Core Tip	The addition of cetuximab to irinotecan containing chemotherapy regimen was sufficient to improve overall survival and progression-free survival in wild-type KRAS metastatic colorectal cancer patients, but not in patients with mutant-type KRAS.
Publish Date	2015-06-18 17:32
Citation	Li XX, Liang L, Huang LY, Cai SJ. Standard chemotherapy with cetuximab for treatment of colorectal cancer. World J Gastroenterol 2015; 21(22): 7022-7035
URL	http://www.wjgnet.com/1007-9327/full/v21/i22/7022.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i22.7022

Full Article (PDF)	WJG-21-7022.pdf
Full Article (Word)	WJG-21-7022.doc
Manuscript File	14656-Review.doc
Answering Reviewers	14656-Answering reviewers.pdf
Copyright License Agreement	14656-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	14656-Language certificate.pdf
Peer-review Report	14656-Peer-review(s).pdf
Scientific Misconduct Check	14656-Scientific misconduct check.pdf
Scientific Editor Work List	14656-Scientific editor work list.pdf